載入...
Successful response to first-line treatment with osimertinib for choroidal metastasis from EGFR-mutated non-small-cell lung cancer
Purpose: Describe the use of osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, as the first-line treatment in a patient with choroidal and central nervous system metastases from EGFR-mutated non-small cell lung cancer. Observations: A 68-year-old man...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2022-06-01
|
| 叢編: | American Journal of Ophthalmology Case Reports |
| 主題: | |
| 在線閱讀: | http://www.sciencedirect.com/science/article/pii/S2451993622002055 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|